HSA-free formulations of interferonbeta
Details for Australian Patent Application No. 2002241769 (hide)
International Classifications
Event Publications
10 April 2003 Application Open to Public Inspection
Published as AU-B-2002241769
4 March 2004 Amendment Made
The nature of the amendment is: Add the following co-inventors: Chen, Bao-Lu and Hora, Maninder.
1 June 2006 Application Accepted
Published as AU-B-2002241769
21 September 2006 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 Sep 2006. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street MELBOURNE VIC 3000
28 September 2006 Standard Patent Sealed
22 February 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 Sep 2006
31 January 2008 Assignment Registered
Chiron Corporation The patent has been assigned to Novartis Vaccines and Diagnostic Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002241768-Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser